McRorie Johnson W, McKeown Nicola M
J Acad Nutr Diet. 2017 Feb;117(2):251-264. doi: 10.1016/j.jand.2016.09.021. Epub 2016 Nov 15.
Enduring misconceptions about the physical effects of fiber in the gut have led to misunderstandings about the health benefits attributable to insoluble and soluble fiber. This review will focus on isolated functional fibers (eg, fiber supplements) whose effects on clinical outcomes have been readily assessed in well-controlled clinical studies. This review will also focus on three health benefits (cholesterol lowering, improved glycemic control, and normalizing stool form [constipation and diarrhea]) for which reproducible evidence of clinical efficacy has been published. In the small bowel, clinically meaningful health benefits (eg, cholesterol lowering and improved glycemic control) are highly correlated with the viscosity of soluble fibers: high viscosity fibers (eg, gel-forming fibers such as b-glucan, psyllium, and raw guar gum) exhibit a significant effect on cholesterol lowering and improved glycemic control, whereas nonviscous soluble fibers (eg, inulin, fructooligosaccharides, and wheat dextrin) and insoluble fibers (eg, wheat bran) do not provide these viscosity-dependent health benefits. In the large bowel, there are only two mechanisms that drive a laxative effect: large/coarse insoluble fiber particles (eg, wheat bran) mechanically irritate the gut mucosa stimulating water and mucous secretion, and the high water-holding capacity of gel-forming soluble fiber (eg, psyllium) resists dehydration. Both mechanisms require that the fiber resist fermentation and remain relatively intact throughout the large bowel (ie, the fiber must be present in stool), and both mechanisms lead to increased stool water content, resulting in bulky/soft/easy-to-pass stools. Soluble fermentable fibers (eg, inulin, fructooligosaccharide, and wheat dextrin) do not provide a laxative effect, and some fibers can be constipating (eg, wheat dextrin and fine/smooth insoluble wheat bran particles). When making recommendations for a fiber supplement, it is essential to recognize which fibers possess the physical characteristics required to provide a beneficial health effect, and which fiber supplements are supported by reproducible, rigorous evidence of one or more clinically meaningful health benefits.
长期以来,人们对膳食纤维在肠道中的生理作用存在误解,这导致了对不溶性纤维和可溶性纤维健康益处的误解。本综述将聚焦于分离的功能性纤维(如纤维补充剂),其对临床结局的影响已在严格控制的临床研究中得到了充分评估。本综述还将聚焦于三种已发表了临床疗效可重复证据的健康益处(降低胆固醇、改善血糖控制以及使粪便形态正常化[便秘和腹泻])。在小肠中,具有临床意义的健康益处(如降低胆固醇和改善血糖控制)与可溶性纤维的粘度高度相关:高粘度纤维(如形成凝胶的纤维,如β-葡聚糖、车前子壳和生瓜尔胶)对降低胆固醇和改善血糖控制具有显著作用,而非粘性可溶性纤维(如菊粉、低聚果糖和小麦糊精)和不溶性纤维(如麦麸)则不具备这些依赖于粘度的健康益处。在大肠中,只有两种机制可产生通便作用:大颗粒/粗的不溶性纤维颗粒(如麦麸)机械性刺激肠道黏膜,刺激水分和黏液分泌,以及形成凝胶的可溶性纤维(如车前子壳)的高持水能力可防止脱水。这两种机制都要求纤维抵抗发酵并在整个大肠中保持相对完整(即纤维必须存在于粪便中),并且这两种机制都会导致粪便含水量增加,从而形成体积大/软/易通过的粪便。可溶性可发酵纤维(如菊粉、低聚果糖和小麦糊精)不具有通便作用,并且某些纤维可能会导致便秘(如小麦糊精和细/光滑的不溶性麦麸颗粒)。在推荐纤维补充剂时,必须认识到哪些纤维具有产生有益健康效果所需的物理特性,以及哪些纤维补充剂得到了一种或多种具有临床意义的健康益处的可重复、严格证据的支持。